Trials / Active Not Recruiting
Active Not RecruitingNCT07278102
A Prospective Observational Study on Efficacy of TARE for Early Stage HCC
A Korean Multicenter Prospective Observational Study on Efficacy of 90Y for Hepatocellular Carcinoma-early Stage
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the current study is to analyze treatment outcomes (best target lesion response, overall survival, time to target lesion progression, time to overall progression, and treatment-related adverse event) using prospectively collected clinical and imaging data in patients with BCLC 0 or A HCCs treated with TheraSphere® in four large-volume hospitals from Korea. The results will pave the way for expanding 90Y-TARE indication and refining reimbursement guidelines, and provide baseline data for possible subsequent future studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transarterial radioembolization | TARE with 90Y |
Timeline
- Start date
- 2022-03-28
- Primary completion
- 2026-01-31
- Completion
- 2026-05-31
- First posted
- 2025-12-11
- Last updated
- 2025-12-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07278102. Inclusion in this directory is not an endorsement.